Li Ying, Gui Yan, Zhao Miaomiao, Chen Xuanqiang, Li Haimei, Tian Chen, Zhao Haoyang, Jiang Chaonan, Xu Pengfeng, Zhang Shiyi, Ye Shaoyong, Huang Manli
Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Key Laboratory of Mental Disorder's Management of Zhejiang Province, Hangzhou, China.
Front Psychiatry. 2023 Mar 9;14:1138110. doi: 10.3389/fpsyt.2023.1138110. eCollection 2023.
Major depressive disorder (MDD) is a serious mental disease characterized by depressed mood, loss of interest and suicidal ideation. Its rising prevalence has rendered MDD one of the largest contributors to the global disease burden. However, its pathophysiological mechanism is still unclear, and reliable biomarkers are lacking. Extracellular vesicles (EVs) are widely considered important mediators of intercellular communication, playing an important role in many physiological and pathological processes. Most preclinical studies focus on the related proteins and microRNAs in EVs, which can regulate energy metabolism, neurogenesis, neuro-inflammation and other pathophysiological processes in the development of MDD. The purpose of this review is to describe the current research progress of EVs in MDD and highlight their potential roles as biomarkers, therapeutic indicators and drug delivery carriers for the treatment of MDD.
重度抑郁症(MDD)是一种严重的精神疾病,其特征为情绪低落、兴趣丧失和自杀意念。其患病率的不断上升已使MDD成为全球疾病负担的最大贡献者之一。然而,其病理生理机制仍不清楚,且缺乏可靠的生物标志物。细胞外囊泡(EVs)被广泛认为是细胞间通讯的重要介质,在许多生理和病理过程中发挥重要作用。大多数临床前研究集中在EVs中的相关蛋白质和微小RNA,它们可调节MDD发生发展过程中的能量代谢、神经发生、神经炎症等病理生理过程。本综述的目的是描述EVs在MDD中的当前研究进展,并强调其作为生物标志物、治疗指标和治疗MDD的药物递送载体的潜在作用。